UVEITIS

This study followed 30 people with uveitis, an eye inflammation condition, who received a fluocinolone acetonide implant. Researchers used special eye scans to measure inflammation changes over 12 months. The goal was to see how the implant affects inflammation and vision.

This study tested the drug adalimumab (Humira) in 34 children with juvenile arthritis who also had active eye inflammation (uveitis) that did not improve with standard steroid drops and methotrexate. After 2 months, more children on adalimumab showed at least a 30% reduction in e…

This study checked if switching from the original drug Remicade to its biosimilar Inflectra works just as well for patients with rheumatoid arthritis, spondyloarthritis, Crohn's disease, or uveitis. 262 adults who had already received at least three doses of Remicade were switche…

This study tested a gel called ACTH gel, given as a shot under the skin, to see if it can help control non-infectious uveitis, a condition that causes swelling inside the eye. The trial included 28 people with active eye inflammation. Researchers looked at how safe the gel was an…

This study tested three biologic drugs (adalimumab, anakinra, and tocilizumab) in 112 people with severe, non-infectious uveitis that did not improve with standard treatments. The goal was to see which drug best reduces eye inflammation and allows patients to lower their steroid …

This study tested whether a standardized, step-by-step diagnostic plan for uveitis (eye inflammation) works as well as letting doctors choose tests freely, while costing less. Over 900 adults with uveitis took part. The goal was to see if the standardized approach could find the …

This study looked at the natural bacteria in the gut of people with and without uveitis, an inflammatory eye disease. Researchers collected stool and blood samples and performed eye exams to see if gut bacteria differ between the two groups. No treatment was given; the goal was s…

This study collected blood, tissue, and other samples from 343 people with uveitis (a serious eye disease) to learn why some people get it and how they respond to treatment. Participants were followed for up to 10 years with eye exams and tests. The goal was to gather information…